Neuropace Inc

NASDAQ:NPCEUnited States

NeuroPace, Inc. is a commercial-stage medical device company. The Company is focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company’s differentiated RNS System is a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source. The Company is developing its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. RNS System is a device that records brain activity data and allows clinicians to monitor patients. RNS System monitors the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorder.

Contact Information

Headquarters

455 N. Bernardo AvenueMOUNTAIN VIEW, CA, United States 94043

Phone

650-237-2700

Fax

650-237-2701

Executives

Chairman of the Board

Frank Fischer

President, Chief Executive Officer, Director

Michael Favet

Vice President - Finance and Administration, Chief Financial Officer

Rebecca Kuhn

General Counsel, Corporate Secretary

Irina Ridley

Chief Medical Officer

Martha Morrell